Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

SINOVAC BIOTECH LTD.

(SVA)
  Report
SummaryQuotesChartsNewsCalendarCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Sinovac Biotech : North Korea turns down Sinovac COVID-19 vaccine doses - WSJ

09/01/2021 | 07:41am EDT

Sept 1 (Reuters) - North Korea has rejected roughly three million COVID-19 vaccine doses developed by China's Sinovac Biotech, saying the shots should be sent to harder-hit countries, the Wall Street Journal reported on Wednesday, citing UNICEF.

The agency, which helps deliver COVID-19 shots on behalf of the COVAX scheme, told WSJ that North Korea's public health ministry declined the shipment, citing the limited global supply for vaccines and continuing virus surges elsewhere.

North Korea had in July rejected shipments of AstraZeneca's COVID-19 vaccine due to concerns over side effects, according to a South Korean think-tank.

The reclusive country has not reported any COVID-19 cases and has imposed strict anti-virus measures, including border closures and domestic travel curbs.

UNICEF did not immediately respond to Reuters' request for comment.

"We continue to work with DPRK authorities to help respond to the COVID-19 pandemic," a spokesperson for the Global Alliance for Vaccines and Immunization alliance, one of the organizations that co-leads COVAX, said in an emailed statement. (Reporting by Manas Mishra in Bengaluru and Sangmi Cha in Seoul; Editing by Ramakrishnan M.)


ę Reuters 2021
Stocks mentioned in the article
ChangeLast1st jan.
ASTRAZENECA PLC -0.22% 8795 Delayed Quote.20.08%
SINOVAC BIOTECH LTD. -0.31% 6.47 Delayed Quote.0.00%
All news about SINOVAC BIOTECH LTD.
10/06SINOVAC BIOTECH : Pfizer study to vaccinate whole Brazilian town against COVID-19
RE
10/01SINOVAC BIOTECH : Malaysia approves Sinovac's COVID-19 vaccine for ages 12 to 17
RE
09/29SINOVAC BIOTECH : Rebuffed by Bolsonaro, Brazil medical institute to sell vaccines abroad
RE
09/24CANSINO BIOLOGICS : CanSinoBIO's COVID vaccine, tested at lower dosage, safe for children ..
RE
09/22SINOVAC BIOTECH : Thailand delays plan to re-open cities to tourists until November
RE
09/15INDONESIA IN TALKS WITH WHO TO BECOM : minister
RE
09/09SINOVAC BIOTECH : Says its New Research Shows Third Dose if its COVID-19 Vaccine More Effe..
MT
09/09SINOVAC BIOTECH : New Research on SINOVAC's COVID-19 Vaccine Shows Third Dose More Effecti..
BU
09/08SINOVAC BIOTECH : Announces COVID-19 Vaccine Approved for Emergency Use in Chile for Child..
BU
09/07SINOVAC BIOTECH : Mixing CanSinoBIO, Sinovac COVID shots induces stronger response than Si..
RE
More news
Financials (USD)
Sales 2020 511 M - -
Net income 2020 110 M - -
Net cash 2020 1 040 M - -
P/E ratio 2020 6,66x
Yield 2020 -
Capitalization 642 M 642 M -
EV / Sales 2019 1,86x
EV / Sales 2020 -0,78x
Nbr of Employees 1 959
Free-Float 33,5%
Chart SINOVAC BIOTECH LTD.
Duration : Period :
Sinovac Biotech Ltd. Technical Analysis Chart | SVA | AGP8696W1045 | MarketScreener
Income Statement Evolution
Managers and Directors
Wei Dong Yin Chairman, President, CEO, Secretary & MD
Nan Wang CFO & Vice President-Business Development
Qiang Gao Chief Operating Officer & Vice President
Yuk Lam Lo Independent Director
Jian Li Independent Director
Sector and Competitors
1st jan.Capi. (M$)
SINOVAC BIOTECH LTD.0.00%642
CSL LIMITED5.08%100 638
WUXI BIOLOGICS (CAYMAN) INC.6.42%59 673
SAMSUNG BIOLOGICS CO.,LTD.5.21%48 619
BIOGEN INC.16.50%41 907
ALEXION PHARMACEUTICALS, INC.0.00%40 336